POSTER SESSION III
Tuesday, March 1, 2011 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
167
The Role of MUC1, MUC2 and MUC7 in the Outcome of Superficial (Ta, T1) Urinary Bladder Cancer (SBC).
(852)
D Kankaya, S Kiremitci, S Baltaci, Z Biyikli, O Tulunay - Medical School of Ankara University, Turkey
Ras Pathway Activated by Loss of ARL11: A Missing Link in Cancer Initiation.
(872)
S Lee, S Lee, J Bondaruk, T Majewski, H Wang, S Zhang, M Bar-Eli, P Black, Y Wang, CC Guo, C Dinney, HB Grossman, M Knowles, K Baggerly, B Czerniak - UT MD Anderson Cancer Center, Houston, TX; St. James's University Hospital, Leeds, United Kingdom
Human Papillomavirus and Non-Muscle Invasive Urothelial Bladder Cancer: Potential Relationship from a Pilot Study.
(901)
G Nesi, T Cai, S Mazzoli, P Geppetti, R Bartoletti - University of Florence, Italy; Santa Chiara Hospital, Trento, Italy; Santa Maria Annunziata Hospital, Florence, Italy
mTOR Pathway Activation in pT1 Urothelial Cell Carcinomas of the Bladder: A Potential Target of Therapy.
(783)
R Cox, A Chaux, J Solus, L Schultz, A Demarzo, E Comperat, GJ Netto - Johns Hopkins University, Baltimore, MD; Hopital Pitie, Paris, France
Her2 Gene Status but Not Protein Expression Stratifies Survival Significantly in Lymph Node Positive Bladder Cancer.
(813)
A Fleischmann, D Rotzer, R Seiler, GN Thalmann - University of Bern, Switzerland
Expression of MUC4 Is Downregulated in Urothelial Carcinoma.
(967)
D Wagner, A Horn, S Kaur, N Momi, M Lele, SK Batra, SM Lele - University of Nebraska Medical Center, Omaha
The Expression and Prognostic Significance of RalA and RalB Expression in Bladder Cancer.
(949)
SC Smith, MD Nitz, AS Baras, DT Theodorescu - University of Michigan Health System, Ann Arbor; University of Virginia Health System, Charlottesville; University of Colorado, Aurora
Distinct Expression Profiles of p63 Isoforms during Bladder Cancer Progression.
(768)
M Castillo-Martin, O Karni-Schmidt, N Gladoun, J Domingo-Domenech, C Cordon-Cardo - Columbia University, New York, NY
Utility of p63 and HMWCK in the Distinction between Urothelial Carcinoma with Prostatic Stromal Invasion and Urothelial Carcinoma with Colonization of Prostatic Ducts and Acini.
(770)
EC Chastain, IV Oliva, AO Osunkoya - Emory University School of Medicine, Atlanta
Cytokeratin 5/6 Distinguishes Reactive Urothelial Atypia from Carcinoma In Situ and Non-Invasive Urothelial Carcinoma.
(798)
A Edgecombe, EC Belanger, B Djordjevic, BN Nguyen, KT Mai - The Ottawa Hospital and University of Ottawa, ON, Canada
Detailed Immunohistochemical (IHC) Evaluation of Novel Markers Associated with Urothelial Differentiation in a Comprehensive Spectrum of Variants of Urothelial Carcinoma (UCa): A Study of 80 Cases.
(745)
C Annaiah, GP Paner, C Gulmann, P Rao, JY Ro, DE Hansel, SS Shen, A Lopez-Beltran, K Arora, RS Parakh, LP Herrera, DJ Luthringer, J Zhai, YM Cho, MB Amin - Beaumont Hospital, Dublin, Ireland; University of Chicago, IL; Cedars-Sinai Medical Center, Los Angeles, CA; Cleveland Clinic, OH; The Methodist Hospital, Houston, TX; Faculty of Medicine, Cordoba, Spain; MD Anderson Cancer Center, Houston, TX
Cancer/Testis (CT) Antigen Expression Correlates with Non-Response to BCG Therapy and Invasive Disease in Human Bladder Cancers.
(926)
BD Robinson, TM D'Alfonso, R Chiu, EC Kauffman, DS Scherr, LJ Old, Y-T Chen - Weill Cornell Medical College, New York; Ludwig Institute for Cancer Research, New York
Immunohistochemical (IHC) Profile To Distinguish Urothelial from Squamous Differentiation in Carcinomas of Urothelial Tract.
(824)
C Gulmann, GP Paner, RS Parakh, DE Hansel, SS Shen, JY Ro, C Annaiah, A Lopez-Beltran, P Rao, K Arora, YM Cho, R Alsabeh, MB Amin - Beaumont Hospital, Dublin, Ireland; University of Chicago, IL; Cedars-Sinai Medical Center, Los Angeles, CA; Cleveland Clinic, OH; The Methodist Hospital, Houston, TX; Faculty of Medicine, Cordoba, Spain; MD Anderson Cancer Center, Houston, TX
Selective Immunohistochemical Markers To Distinguish between Metastatic High Grade Urothelial Carcinoma to the Lung and Primary Poorly Differentiated Invasive Squamous Carcinoma.
(823)
AM Gruver, D Westfall, CF Farver, DJ Luthringer, AO Osunkoya, JK McKenney, MB Amin, DE Hansel - Cleveland Clinic, OH; Cedars-Sinai Medical Center, Beverly Hills, CA; Emory University School of Medicine, Atlanta, GA; Stanford University School of Medicine, CA
Splicing Variants of Carbonic Anhydrase IX in Bladder Cancer and Urine Sediments.
(900)
G Nesi, F Malentacchi, S Vinci, D Villari, C Selli, C Orlando - University of Florence, Italy; University of Pisa, Italy
Expression of Putative Stem Cell Markers ALDH1 and CD133 in Urothelial Carcinoma of the Bladder.
(886)
A Matoso, KT Sciandra, S Elsamra, K Singh, J Renzulli, R Jacob, R Tavares, G Haleblian, L Noble, G Pareek, MB Resnick, LJ Wang - Rhode Island Hospital/Brown University, Providence
A Comparison of Proliferation Markers in Urothelial Carcinomas of the Urinary Bladder.
(883)
OM Mangrud, BD Hidle, R Waalen, E Gudlaugsson, EAM Janssen, JPA Baak - Stavanger University Hospital, Norway; University of Bergen, Norway; Innlandet Hospital Trust, Lillehammer, Norway
Reproducibility of Grading Papillary Urothelial Carcinoma of Bladder. Utility of RB, P53 and KI-67.
(816)
Y Gong, JS Hou, X Chen, RT Ownbey, BL Mapow, FU Garcia - Drexel University College of Medicine, Philadelphia, PA
Urinary Met Level as a Novel Biomarker for Urothelial Carcinoma of the Bladder.
(951)
M Sorbellini, B McNeal, G Athauda, B Cohen, A Giubellino, H Simpson, J Coleman, RH Getzenberg, GJ Netto, MW Linehan, PA Pinto, DP Bottaro - National Cancer Institute, Bethesda, MD; Memorial Sloan Kettering Cancer Center, New York, NY; Johns Hopkins University, Baltimore, MD
High Nuclear Cyclin D1 Expression in Lymph Node Metastases from Bladder Cancer Is an Independent Risk Factor for Early Death.
(812)
A Fleischmann, D Rotzer, GN Thalmann, R Seiler - University of Bern, Switzerland
Enrichment of Cancer Stem Cells in Urothelial Carcinoma and Small Cell Carcinoma of the Urinary Bladder.
(947)
Q Si, L Xiao, Y Bondaruk, Y Wang, B Czerniak, CC Guo - University of Texas MD Anderson Cancer Center, Houston
Evaluation of UroVysion. FISH and Cytology Testing . Concordance and Cost Effectiveness Comparison between Cotesting vs. Non-Cotesting Samples.
(882)
N Manglik, P Wasserman, S Sheikh-Fayyaz, N Morgenstern - North Shore Long Island Jewish Health System, New Hyde Park, NY
Reflex UroVysion Testing in Abnormal Urine Cytology: Surveillance Versus Initial Evaluation.
(896)
JW Mooring, M Lowery-Nordberg, S Zhang - Louisiana State University Health Sciences Center, Shreveport, Shreveport; Feist Weiller Cancer Center, Shreveport, LA
Urothelial Carcinoma with Lymphoepithelioma like Carcinoma Features: A Clinicopathologic Study of Ten Patients.
(977)
A Wu, J Montie, D Smith, LP Kunju - University of Michigan Medical Center, Ann Arbor
Primary Carcinoid Tumors of the Urinary Bladder and Prostatic Urethra: A Clinicopathologic Study of 7 Cases.
(776)
Y-B Chen, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD
Plasmacytoid Carcinoma of the Urinary Bladder: An Invasive Urothelial Carcinoma Subtype with Important Staging and Follow-Up Implications.
(924)
R Ricardo, M Nguyen, N Gokden, A Sangoi, J Presti, Jr, J McKenney - Stanford, Stanford, CA; University of Arkansas for Medical Sciences, Little Rock; El Camino Hospital, Mountain View, CA
Histopathologic Features of Preoperative Transurethral Prostatic Urethral Biopsy Specimens in Patients with Bladder Cancer.
(945)
SS Shen, JY Ro, AG Ayala - The Methodist Hospital and Weill Medical College of Cornell University, Houston
Necessity and Usefulness of Pathological T1 Subclassfication in the Management of Bladder Urothelial Carcinoma.
(958)
H Takahashi, T Yamamoto, S Mizukami, M Furusato, S Egawa, M Fujime, H Hano - The Jikei University School of Medicine, Tokyo, Japan; School of Medicine, Juntendo University, Tokyo, Japan
Common Diagnostic Problems in Interpretation of Early Invasive Bladder Cancer: A Consensus Study.
(944)
SS Shen, CC Guo, JY Ro, R Anton, L Cheng, O Hameed, LD Truong, J Huang, MA Weiss, F Lin, JR Srigley, JK McKenney, P Tamboli, DJ Grignon, RE Jimenez, M Zhou, GP Paner, P Troncoso, MB Amin, AG Ayala - The Methodist Hospital, Houston; UT M.D. Anderson Cancer Center, Houston; Univ. of Indiana, Indianapolis; Univ. of Alabama at Birmingham; Univ. of California Los Angeles; The Urology Group, Cincinnati; Geisinger Medical Center, Danville; Credit Valley Hospital, Mississauga, ON, Canada; Stanford Univ., Stanford; Mayo Clinic, Rochester; Cleveland Clinic; Univ. of Chicago; Cedars-Sinai Medical Center, Los Angeles
Urinary Bladder Sinuses. A New Pathological Finding with Clinical and Pathological Significance.
(846)
T Jayasinghe, B Djordjevic, EC Belanger, SJ Robertson, BN Nguyen, KT Mai - The University of Ottawa, ON, Canada
Measuring Dimension of Tumor Invasion of Urothelial Carcinoma (UCa) in Transurethral Resection Predicts Time of Recurrence.
(837)
Z Hu, GP Paner, K Mudaliar, GA Barkan - Loyola University, Maywood, IL; University of Chicago Hospital, IL
Frozen Section (FS) Analysis of Cancer Containing Bladder Transurethral Resection Specimens (TURB) for the Presence of Muscularis Propia (MP) Invasion.
(822)
R Goyal, S Bishu, V Parimi, XJ Yang, SM Rohan - Northwestern University Feinberg School of Medicine, Chicago, IL
button next to any title to add to Itinerary Planner...
Add
